From innovation to sanctions?

Routine practice data collection

Title: "Vom Innovations- zum Sanktionssystem?" | Authors: Prof. Matthias P. Schönermark M.D., Ph.D., Dr. rer. nat. Laura Könenkamp, Dr. rer. nat. Ingo Hantke | market access & health policy 03/2023

SKC has published a whitepaper entitled "Routine practice data collection for benefit assessment: Lessons learned from 2 years - risk factors and strategic implications". The German journal "Market Access and Health Policy" interviewed the authors, Prof. Matthias P. Schönermark M.D., Ph.D., Dr. rer. nat. Laura Könenkamp and Dr. rer. nat. Ingo Hantke, about the possibilities of routine practice data collection (anwendungsbegleitende Datenerhebung, AbD) and the future development of early benefit assessment for therapies with initially poor data.


Here you can download our publication free of charge (only in German language available).

market access & health policy 03/2023
Vom Innovations- zum Sanktionssystem? - Interview zur Anwendungsbegleitenden Datenerhebung
2nd to 4th of Oct 2023
Prof. Matthias P. Schönermark, M.D., Ph.D.

Excellence for Market & Patient Access, Pricing and Reimbursement


Market Access Strategy

We can build your sound market access strategy at an early stage, giving you and all parties involved valuable orientation throughout the entire market access process.
to the top